Table of Contents

Clinical Studies

• Open Access

  Prognostic Role of Porphyromonas gingivalis Gingipain Rgp and Matrix Metalloproteinase 9 in Oropharyngeal Squamous Cell Carcinoma

  ANNA KAISA KYLMÄ, TIMO SORSA, LAURI JOUHI, HARRI K. MUSTONEN, HESHAM MOHAMED, REIJA RANDÉN-BRADY, ANTTI MÄKITIE, TIMO ATULA, JAANA HAGSTRÖM and CAJ HAGLUND

  Anticancer Research November 2022, 42 (11) 5415-5430; DOI: https://doi.org/10.21873/anticanres.16046
• Open Access

  Letermovir Prophylaxis for CMV Reactivation in Allogeneic Stem Cell Recipients: A Retrospective Single Center Analysis

  KATRIN KOCH, LENA OSSWALD, ISABELLA MILLER, KRISCHAN BRAITSCH, KATHARINA GÖTZE, FLORIAN BASSERMANN, PETER HERHAUS and MAREIKE VERBEEK

  Anticancer Research November 2022, 42 (11) 5431-5441; DOI: https://doi.org/10.21873/anticanres.16047
• Open Access

  Vascularized and Non-vascularized Fibula Grafts in Tumour Reconstruction: Single Centre Experience With Mid to Long-term Results

  SABINA M. GORSKI, CHAO DONG, ULRICH LENZE, MARTIN HAUG and ANDREAS. H. KRIEG

  Anticancer Research November 2022, 42 (11) 5443-5447; DOI: https://doi.org/10.21873/anticanres.16048
• You have access

  Impact of Routine Surveillance Imaging on Recurrence in Sinonasal Malignancies

  KEVIN KING, RYAN RAUCH, SOUMYAJIT ROY, OLEG MENYOK, KEN TATEBE, BOBBY TAJUDEEN, PETER PAPAGIANNOPOULOS, PETE S. BATRA, MIHIR BHAYANI, SAMER AL-KHUDARI, KIRSTEN STENSON, MICHAEL J. JELINEK, MARY JO FIDLER and NIKHIL JOSHI

  Anticancer Research November 2022, 42 (11) 5449-5455; DOI: https://doi.org/10.21873/anticanres.16049
• Open Access

  Effect of Palliative Care Decision on Use of Hospital Services in Pancreatic Cancer Patients: A Retrospective Study

  SOFIA MIINALAINEN, ANTTI RISSANEN, RIIKKA-LEENA LESKELA, TIINA SAARTO, OUTI HIRVONEN and ANU ANTTONEN

  Anticancer Research November 2022, 42 (11) 5457-5463; DOI: https://doi.org/10.21873/anticanres.16050
• You have access

  Initial Experience With Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma: A Real-world Retrospective Study

  SOICHI TAKEDA, TADASHI NAMISAKI, YUKI TSUJI, YUKI FUJIMOTO, KOJI MURATA, MASAHIDE ENOMOTO, YUKIHISA FUJINAGA, NORIHISA NISHIMURA, KOH KITAGAWA, HIROAKI TAKAYA, KOSUKE KAJI, TAKASHI INOUE, HIDETO KAWARATANI, TAKEMI AKAHANE, AKIRA MITORO and HITOSHI YOSHIJI

  Anticancer Research November 2022, 42 (11) 5465-5473; DOI: https://doi.org/10.21873/anticanres.16051
• You have access

  Molecular Characteristics and Immunogenomic Profiling of Cholangioblastic Variant of Intrahepatic Cholangiocarcinoma in a 68-year-old Patient

  GRACE HUANG, LEONARD N. HOWARD, EDGAR ALONSOZANA, DAVID SILL, DEBASHISH BOSE and JINPING LAI

  Anticancer Research November 2022, 42 (11) 5475-5478; DOI: https://doi.org/10.21873/anticanres.16052
• You have access

  Rechallenge With Lenvatinib After Atezolizumab Plus Bevacizumab Treatment for Hepatocellular Carcinoma

  SHOHEI KOMATSU, YOSHIHIKO YANO, MASAHIRO KIDO, KAORI KURAMITSU, HIDETOSHI GON, KENJI FUKUSHIMA, TAKESHI URADE, SHINICHI SO, ATSUSHI YAMAMOTO, TADAHIRO GOTO, HIROAKI YANAGIMOTO, HIROCHIKA TOYAMA, YOSHIHIDE UEDA, YUZO KODAMA and TAKUMI FUKUMOTO

  Anticancer Research November 2022, 42 (11) 5479-5486; DOI: https://doi.org/10.21873/anticanres.16053
• Open Access

  PTX Treatment of Colon Cancer: Mode of Action Based on Tumor Marker and Cytokine Kinetics

  AMICHAY MEIROVITZ, LEA BAIDER, TAMAR PERETZ, SAMIR STEPHANOS and VIVIAN BARAK

  Anticancer Research November 2022, 42 (11) 5487-5496; DOI: https://doi.org/10.21873/anticanres.16054
• You have access

  Efficacy of Adjuvant Chemotherapy Following Curative Resection of Colorectal Cancer Liver Metastases

  KAZUHISA TAKEDA, YUTARO KIKUCHI, YU SAWADA, TAKAFUMI KUMAMOTO, JUN WATANABE, CHIKARA KUNISKI, TOSHIHIRO MISUMI and ITARU ENDO

  Anticancer Research November 2022, 42 (11) 5497-5505; DOI: https://doi.org/10.21873/anticanres.16055
• You have access

  Surgery, Limb Edema and Health-related Quality of Life: A Prospective Follow-up Study on Patients With Cutaneous Malignant Melanoma

  PIA HEINO, PIA MYLLÄRI, TIINA JAHKOLA, MINNA-LIISA LUOMA, PIRJO RÄSÄNEN and RISTO P. ROINE

  Anticancer Research November 2022, 42 (11) 5507-5519; DOI: https://doi.org/10.21873/anticanres.16056
• Open Access

  Interleukin-18 (IL-18) Cytokine Serum Concentrations Correlate With Pain Scores and the Number of Analgesic Doses Following Surgery

  MAARET ESKELINEN, IINA SAIMANEN, TUOMAS SELANDER, ANU HOLOPAINEN, SAMULI ASPINEN, ESA HÄMÄLÄINEN and MATTI ESKELINEN

  Anticancer Research November 2022, 42 (11) 5521-5526; DOI: https://doi.org/10.21873/anticanres.16057
• You have access

  Pre-and Postoperative Circulating Tumour DNA in Patients With Gastrointestinal Stromal Tumour – A Methodological Assessment Study

  CHARLOTTE MARGARETA BRINCH, NINNA AGGERHOLM-PEDERSEN, TIM SVENSTRUP POULSEN, WOJCIECH SKOVRIDER-RUMINSKI, PIETER DE HEER, LUIT PENNINGA, ANDERS KRARUP-HANSEN and ESTRID HOGDALL

  Anticancer Research November 2022, 42 (11) 5527-5537; DOI: https://doi.org/10.21873/anticanres.16022
• You have access

  Neoadjuvant Therapy for Patients With Non-small Cell Lung Cancer Complicated With Chest Wall Invasion

  KEIYU SATO, SHOTA NAKAMURA, YUKA KADOMATSU, HARUSHI UENO, TAKETO KATO, NAOKI OZEKI, KOICHI FUKUMOTO and TOYOFUMI FENGSHI CHEN-YOSHIKAWA

  Anticancer Research November 2022, 42 (11) 5539-5546; DOI: https://doi.org/10.21873/anticanres.16059
• You have access

  Association Between a High Gene Expression Variant of Chymase and Increased Risk for Basal Cell Carcinoma

  SEVASTIANA CHARALAMPIDOU, IPHIGENIA GINTONI, DIMITRIS AVGOUSTIDIS, VERONICA PAPAKOSTA, DIMITRIOS VLACHAKIS, STAVROS VASSILIOU and CHRISTOS YAPIJAKIS

  Anticancer Research November 2022, 42 (11) 5547-5552; DOI: https://doi.org/10.21873/anticanres.16060
• You have access

  Clinical Significance of Early Recurrence After Curative Resection of Colorectal Cancer

  NATSUKO YAMAUCHI, TAKERU MATSUDA, RYUICHIRO SAWAD, HIROSHI HASEGAWA, KIMIHIRO YAMASHITA, HITOSHI HARADA, NAOKI URAKAWA, HIRONOBU GOTO, SHINGO KANAJI, TARO OSHIKIRI and YOSHIHIRO KAKEJI

  Anticancer Research November 2022, 42 (11) 5553-5559; DOI: https://doi.org/10.21873/anticanres.16061
• Open Access

  Distress Scores During a Course of Radiotherapy: A Pilot Study

  CANSU DELIKANLI, STEFAN JANSSEN, DIRK KEIL, SØREN TVILSTED, STEVEN E. SCHILD and DIRK RADES

  Anticancer Research November 2022, 42 (11) 5561-5566; DOI: https://doi.org/10.21873/anticanres.16062
• You have access

  Prognostic Significance of the Nodal Ratio and Number of Positive Nodes in Patients With Squamous Cell Carcinomas of the Head and Neck

  ISABELL REUTER, HANS-HELGE MÜLLER and SUSANNE WIEGAND

  Anticancer Research November 2022, 42 (11) 5567-5570; DOI: https://doi.org/10.21873/anticanres.16063
• You have access

  The Significance of Staging Laparoscopy in Detection of Radiologically Occult Peritoneal Carcinomatosis in Gastric Cancer With Gastric Outlet Obstruction: Consideration of The Optimal Treatment Approach

  MASARU KOMATSU, TAKAHIRO KINOSHITA, EIGO AKIMOTO, MITSUMASA YOSHIDA, DAIKI TERAJIMA, HIROMI NAGATA, TAKUMI HABU, TAKAFUMI OKAYAMA, YUYA TAKABE, JUNICHIRO HARADA, MASAYUKI YAMAGUCHI and MASAHIRO YURA

  Anticancer Research November 2022, 42 (11) 5571-5578; DOI: https://doi.org/10.21873/anticanres.16064
• You have access

  Hispanic vs. Caucasian Race/Ethnicity in Adrenocortical Carcinoma Patients

  ANDREA PANUNZIO, STEFANO TAPPERO, CRISTINA CANO GARCIA, MATTIA PICCINELLI, FRANCESCO BARLETTA, REHA-BARIS INCESU, ZHE TIAN, ALESSANDRO TAFURI, DERYA TILKI, ALBERTO BRIGANTI, OTTAVIO DE COBELLI, FELIX K.H. CHUN, CARLO TERRONE, FRED SAAD, SHAHROKH F. SHARIAT, ISABELLE BOURDEAU, MARIA ANGELA CERRUTO, ALESSANDRO ANTONELLI and PIERRE I. KARAKIEWICZ

  Anticancer Research November 2022, 42 (11) 5579-5585; DOI: https://doi.org/10.21873/anticanres.16065
• You have access

  Neoadjuvant Modified Short-course Radiotherapy for Stage IV Rectal Cancer

  HIROSHI DOI, MASAYUKI FUJIWARA, NAOHITO BEPPU, HIROYUKI YOKOYAMA, SHOGO HARUI, AYAKO SUGIHARA, HIDENORI YANAGI, YOSHIO HISHIKAWA, NAOKI YAMANAKA and NORIHIKO KAMIKONYA

  Anticancer Research November 2022, 42 (11) 5587-5595; DOI: https://doi.org/10.21873/anticanres.16066
• You have access

  Detection of Recurrence After Primary Treatment for Oropharyngeal Carcinoma

  FREDRIK LANDSTRÖM, JOHAN REIZENSTEIN and STEFAN KRISTIANSSON

  Anticancer Research November 2022, 42 (11) 5597-5600; DOI: https://doi.org/10.21873/anticanres.16067
• You have access

  Clinicopathological Characterization of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

  HA YOUNG WOO, SEOUNG WAN CHAE, SUNG-IM DO and KIYONG NA

  Anticancer Research November 2022, 42 (11) 5601-5608; DOI: https://doi.org/10.21873/anticanres.16068
• You have access

  Potential Utility of the Mallampati Score for Prediction of Treatment Compliance and Safety Profiles of Patients With Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiotherapy

  PO-HSU SU, CHIH-CHUNG HSU, SHUN-WEN HSUEH, CHIA-YEN HUNG, KUN-YUN YEH, HUNG-MING WANG, CHANG-HSIEN LU, YU-CHING LIN, JOSEPH TUNG-CHIEH CHANG and WEN-CHI CHOU

  Anticancer Research November 2022, 42 (11) 5609-5618; DOI: https://doi.org/10.21873/anticanres.16069
• You have access

  Thyroglobulin Levels as a Predictor of Papillary Cancer Recurrence After Thyroid Lobectomy

  JIN-SEONG CHO and HEE KYUNG KIM

  Anticancer Research November 2022, 42 (11) 5619-5627; DOI: https://doi.org/10.21873/anticanres.16070
• Open Access

  A Survival Score for Very Elderly Patients With Brain Metastases Assigned to Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy

  DIRK RADES, CANSU DELIKANLI, OLIVER BLANCK, STEVEN E. SCHILD and STEFAN JANSSEN

  Anticancer Research November 2022, 42 (11) 5629-5634; DOI: https://doi.org/10.21873/anticanres.16071
• You have access

  The Clinical Impact of Other Primary Cancer in Patients Who Received Curative Treatment for Esophageal Cancer

  TORU AOYAMA, YUKIO MAEZAWA, KENTARO HARA, MIWHA JU, KEISUKE KOMORI, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, KEISUKE KAZAMA, SHO SAWAZAKI, ITARU HASHIMOTO, KAZUKI KANO, HARUHIKO CHO, JUNYA MORITA, KENKI SEGAMI, TETSUSHI ISHIGURO, TSUTOMU SATO, TAKASHI OSHIMA, NORIO YUKAWA and YASUSHI RINO

  Anticancer Research November 2022, 42 (11) 5635-5641; DOI: https://doi.org/10.21873/anticanres.16072
• You have access

  Gustave Roussy Immune Score for Predicting Postoperative Complications and Non-cancer Death in Elderly Patients With Colon Cancer

  TETSURO TOMINAGA, TAKASHI NONAKA, SHOSABURO OYAMA, YUMA TAKAMURA, SHINTARO HASHIMOTO, TOSHIO SHIRAISHI, TERUMITSU SAWAI and TAKESHI NAGAYASU

  Anticancer Research November 2022, 42 (11) 5643-5653; DOI: https://doi.org/10.21873/anticanres.16073
• You have access

  Evaluating Neoadjuvant Chemotherapy for Lower Esophageal Squamous Cell Carcinoma by Measuring Esophageal Wall Thickness

  HIROMICHI SATO, KAZUHIRO NISHIKAWA, TAKUYA HAMAKAWA, CHIKAKO KUSUNOKI, MASAKAZU MIYAKE, ATSUSHI MIYAMOTO, TAKESHI KATO, MASAYUKI MANO, KOJI TAKAMI and MOTOHIRO HIRAO

  Anticancer Research November 2022, 42 (11) 5655-5662; DOI: https://doi.org/10.21873/anticanres.16074
• You have access

  Vater Papilla-preserving Strategy for Advanced Hepatocellular Carcinoma With Excessive Bile Duct Tumor Thrombus

  KENSUKE YAMAMURA, TORU BEPPU, KEIJIRO INOUE, KAZUKI MATSUMURA, ERI ODA, YASUNORI NAGAYAMA, TOSHIHIKO MOTOHARA, HIDEAKI MIYAMOTO, YOSHIHIRO KOMOHARA, HIROHISA OKABE, TATSUNORI MIYATA and TAKATOSHI ISIKO

  Anticancer Research November 2022, 42 (11) 5663-5670; DOI: https://doi.org/10.21873/anticanres.16075